This patented invention is an internet-based laboratory data management system that can be used to create protocols, collect and organize data, archive long-term records, and facilitate scientific collaboration among researchers.
A team of Stanford researchers have developed a simple, novel, non-viral technique for generating human induced pluripotent stem cells (hiPSCs) with minicircle DNA. This technology uses a single minicircle vector that expresses four reprogramming factors.
A team of Stanford researchers has developed a novel method for quickly and efficiently generating human induced pluripotent stem cells (hiPSCs) using human adipose stem cells (hASCs) as the starting population.
This is a cell line, AC6.21, from the murine cell line of 6C3Ag^hi phenotype. The cell line supports the proliferation and differentiation of pre-B cells from their hematopoietic precursors in vitro.
Researchers in Prof. Robert Byer's laboratory have developed a new fiber laser technology for generating frequency combs with broadband output (an octave or more).
Researchers in the Ginzton lab at Stanford University have patented an all-dielectric laser-driven microstructure for producing controllable charged particle beam.
Stanford researchers have developed a highly specific, tunable system to improve the safety, efficacy and deliverability of gene therapy vectors and other biological therapies.
Researchers in Dr. Michael Cleary's laboratory at Stanford University have developed a highly specific monoclonal antibody for AF4, a proto-oncoprotein associated with pediatric and adult leukemia.
Researchers in Dr. Michael Cleary's laboratory at Stanford University have developed a highly specific monoclonal antibody for ENL, a proto-oncoprotein associated with pediatric and adult leukemia.
Rat monoclonal antibody BZ194 specifically recognizes mouse serpentine receptor mCMKLR1 (aka ChemR23, DEZ). mCMKLR1 is a novel protein possessing high homology with members of the chemoattractant receptor family, and binds the chemoattractant chemerin.